近日，SCIENCE CHINA Life Sciences在线发表中山大学中山医学院向秋玲教授和项鹏教授团队题为“Human iPSC-Derived Mesenchymal Stem Cells Relieve High Blood ...

Mesenchymal stem cells are multipotent adult stem cells that are present in multiple tissues, including umbilical cord, bone marrow and fat tissue. Mesenchymal stem cells can self-renew by ...

Techniques that cause multipotent adult mesenchymal stem cells (MSCs) to differentiate into cells of the chondrogenic lineage have led to a variety of experimental strategies to investigate ...

The simple injection has shown promise in everything from preventing heart disease and diabetes to curing life-threatening autoimmune illness.

A cross-disciplinary team, led by the University of Glasgow, alongside the Universities of Nottingham and Strathclyde, will ...

Eterna Therapeutics collaborates with Factor Bioscience to speed up cell therapy development for oncology, autoimmune & rare diseases: Cambridge, Massachusetts Saturday, October 1 ...

At six months post-grafting surgery with NVDX3, x-rays demonstrate that 90% of patients have reached, or are steadily ...

Cynata Therapeutics (ASX:CYP) is the only clinical-stage company in the world trialing induced pluripotent stem cells (IPSCs) ...

The site will add state-of-the-art CGT capacity and employ artificial intelligence and automation to achieve critical product ...

Taiwan-based REGiMMUNE, a biopharma creating immunotherapies through the power of regulatory T cells (Tregs), and ...

Eterna Therapeutics and Factor Bioscience announced an exclusive license and collaboration agreement aimed at accelerating ...